A mitochondria-targeted <i>S</i> -nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury

Tracy A. Prime, Frances H. Blaikie, Cameron Evans, Sergiy M. Nadtochiy, Andrew M. James, Christina C. Dahm, Darío A. Vitturi, Rakesh P. Patel, C. Robin Hiley, Irina Abakumova,

Proceedings of the National Academy of Sciences · 2009 · 218 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Nitric oxide (NO(*)) competitively inhibits oxygen consumption by mitochondria at cytochrome c oxidase and S-nitrosates thiol proteins. We developed mitochondria-targeted S-nitrosothiols (MitoSNOs) that selectively modulate and protect mitochondrial function. The exemplar MitoSNO1, produced by covalently linking an S-nitrosothiol to the lipophilic triphenylphosphonium cation, was rapidly and extensively accumulated within mitochondria, driven by the membrane potential, where it generated NO(*) and S-nitrosated thiol proteins. MitoSNO1-induced NO(*) production reversibly inhibited respiration at cytochrome c oxidase and increased extracellular oxygen concentration under hypoxic conditions. MitoSNO1 also caused vasorelaxation due to its NO(*) generation. Infusion of MitoSNO1 during reperfusion was protective against heart ischemia-reperfusion injury, consistent with a functional modification of mitochondrial proteins, such as complex I, following S-nitrosation. These results support the idea that selectively targeting NO(*) donors to mitochondria is an effective strategy to reversibly modulate respiration and to protect mitochondria against ischemia-reperfusion injury.

References

13